Linde plc (LIN) Stock: Price, Forecast & Analyst Target
Linde plc (LIN) — MoonshotScore 76/100 (Strong band), calculated Nov 18, 2026. Price $512.16 (-0.57%), as of the Nov 18, 2026 trading session; market cap $235B. Expected results Feb 4, 2027.
Educational signal · not a buy or sell recommendation · How to read this
Linde plc · LIN · NASDAQ · Basic Materials · Chemicals - Specialty
Research dated 2026-09-12: Linde sells atmospheric and process gases across industries that cannot readily substitute away from oxygen, nitrogen, hydrogen, helium and specialty gases, while its engineering arm designs and builds the plants that produce them. The case now depends on whether rising sales and earnings can restore operating profit conversion while heavy project spending and a debt-heavy balance sheet continue to absorb cash.
Price as of Nov 18, 2026
Key Statistics
MoonshotScore v2 · Linde (LIN)
StrongWhy this rating? Method, drivers & history
Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.
- Business Quality — Is this a genuinely good business?
- Financial Safety — Could this blow up on me?
- Valuation — Am I paying a fair price?
- Growth Durability — Is the growth real and likely to last?
- Momentum — Is the market already moving on this?
High quality and durable growth, but an expensive valuation; the market is already moving on it. Business Quality: Elite; Financial Safety: Sound; Valuation: Rich; Growth Durability: Compounding; Momentum: Surging.
Enterprise value relative to EBITDA is the main valuation drag relative to sector peers.
- EPS beat 0 of the last 4 reports
- expected results Feb 4, 2027
- Altman Z 4.11 · Piotroski F 7
Holding back: a rich price
Helping: business quality, durable growth, positive momentum
What has the MoonshotScore done over time?
| Recorded | Score | Band |
|---|---|---|
| 74 | Strong | |
| 75 | Strong | |
| 74 | Strong | |
| 74 | Strong | |
| 76 | Strong | |
| 76 | Strong |
Daily score refresh is delayed. This is the last recorded calculation.
Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.
Computed · How the MoonshotScore is computed →
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $512.16 | |
| Change on the day | -0.57% | |
| 52-week range | $387.78–$548.20 | |
| Market capitalisation | $235B | — |
| Price / earnings (trailing) | 34.07 | |
| Shares traded on the day | 1.37M | |
| Beta (volatility vs the S&P 500) | 0.68 |
Why Linde scores 76
Share price, last 12 months +24.0%
$420.67 $521.78
What the price assumes
18.7% a year of free-cash-flow growth for ten years is what a $239.54B market value ( snapshot) asks for.
The price already assumes faster growth than the last 5 years delivered. Anything short of an acceleration leaves room to disappoint. It also runs ahead of the analysts' revenue path.
Reverse discounted cash flow: 10% discount rate, 3% growth after year ten, starting from trailing twelve months free cash flow of $5.08B. Inputs: FMP statements, estimates and quote.
How the stock reacts to earnings
EPS beat in 7 of the last 12 reports (2024–2026); the stock still fell the next session after 4 of those beats. Average first-session move: 2.8% either way.
- +4.0%Feb ’24
- -4.3%May ’24
- -2.2%Aug ’24
- -3.4%Oct ’24
- +0.3%Feb ’25
- +0.4%May ’25
- +1.6%Aug ’25
- -4.1%Oct ’25
- -5.3%Feb ’26
- -1.5%May ’26
- -5.5%Jul ’26
- +1.2%Oct ’26
Every report, with revenue and five-session moves
| Report | EPS | Revenue | Next session | 5 sessions |
|---|---|---|---|---|
| Beat | Beat | +1.2% | +2.6% | |
| In line | Beat | -5.5% | -3.7% | |
| Beat | Beat | -1.5% | -1.6% | |
| In line | Beat | -5.3% | -0.1% | |
| In line | In line | -4.1% | -2.2% | |
| Beat | Beat | +1.6% | +2.6% | |
| In line | Miss | +0.4% | 0.0% | |
| In line | Miss | +0.3% | +1.6% | |
| Beat | In line | -3.4% | -1.7% | |
| Beat | In line | -2.2% | -1.4% | |
| Beat | Miss | -4.3% | -2.9% | |
| Beat | Beat | +4.0% | +3.9% |
Beating the estimate has not been enough: the stock fell after 4 of the last 7 beats. The bar it has to clear is the whisper number, not the published one.
What management is saying differently
Management's own words on the Q3 FY2026 call () against Q2 FY2026 (). Analysts' questions are left out.
- New this call: “cost pass-through”, “north america”, “supply chain”, “run rate” — none of them came up in Q2 FY2026.
- Getting louder: “cash flow” (3 → 6 mentions), “organic growth” (1 → 5 mentions).
- Tone: Cautious words such as “may”, “could” and “headwind” fell from 4.8 to 3.3 per 1,000 words, and confident words such as “record” and “strong” rose from 1.7 to 3.2.
Management sounded more assured than a quarter earlier — fewer hedging words, more of the confident kind.
Our track record on this stock
Since the score went from 69 to 76 while the share price moved +4.6% through .
The score has stayed in the Strong band across the stretch we have recorded; we grade each band change three months after it happens.
The crowd against our signals
- Analysts: 90% of 30 rate it a buy; the average target sits +9.0% from the price of $512.16.
- Last 90 days: 9 rating actions, every one a reaffirmation.
- Our signals: Strong band; strongest pillar Momentum (89), weakest Valuation (20).
Here we and the crowd agree. Where we differ is on price: our Valuation reading is more cautious than the analysts' targets.
Price & events
Triangles mark reported quarters on the line: pointing up is above the recorded estimate, down is below, a diamond means no estimate on file. Numbers key to the dated list. Point at or tab to any week for its close.
Events behind the price
- · Earnings results · above the recorded estimate
- · Earnings results · above the recorded estimate
- · Earnings results · above the recorded estimate
- · Earnings results · above the recorded estimate
Results dates follow the earnings feed; call dates follow the transcript provider. Nearby dates do not establish that an event caused a price move.
Upcoming events
How to read these dates
Estimated dates can change.
Other perspectives
Council score for Linde (LIN): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
5-Factor Breakdown
Legends Council
4 lenses, 4 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Nov 19, 2026
Munger's Mindset
Balance Sheet & Valuation
Read on: Nov 19, 2026
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
The Munger lens reads the current price as fairly valued against its own estimate of value.
Readings on this page are from Nov 20, 2026, except a card that shows its own read date.
What is Linde (LIN), and what does it report?
Short answer · as of
Linde is not primarily a specialty-chemical formulator.
Research dated 2026-09-12.
It supplies gases used in healthcare, manufacturing, steel, electronics, energy, food processing and water treatment, then complements that supply business by building air-separation, hydrogen, synthesis-gas and related process plants for outside customers and its own network.
Reporting separates an engineering segment from regional operations across the Americas, Europe, the Middle East, Africa and Asia Pacific. The Americas contribute the largest portion of reported segment revenue, while engineering is much smaller, so consolidated revenue mainly reflects geographically distributed gas operations rather than plant construction alone.
What do the latest results show for Linde (LIN)?
Research dated 2026-09-12.
Revenue has advanced through the recent quarterly sequence, and the latest period also produced higher gross profit, net income and diluted earnings than the preceding period. Operating profit moved the other way, making margin conversion the important tension inside otherwise improving headline results.
Reported earnings have continued to clear expectations, while revenue performance against expectations has shifted from earlier shortfalls to recent beats. Management describes the latest margin pressures as temporary and expects recovery in the coming quarter; that expectation remains a management claim until operating profit strengthens alongside sales.
Where is operating spending going?
Revenue alongside research and development, selling, general and administrative expenses, and the FMP standardized operating result.
| Period end | Revenue | R&D | SG&A | FMP standardized operating result |
|---|---|---|---|---|
| Sep 30, 2026 | Not available | Not available | Not available | Not available |
| Jun 30, 2026 | Not available | Not available | Not available | Not available |
| Mar 31, 2026 | Not available | Not available | Not available | Not available |
| Dec 31, 2025 | Not available | Not available | Not available | Not available |
How to read these figures
Amounts are in US dollars. The operating result is Financial Modeling Prep’s standardized figure, so it can differ from the operating line in the company’s filing. It is not net income or cash flow.
Did results meet expectations?
Reported earnings and revenue alongside the estimates recorded by the provider.
- Latest report · revenue
- $9.40B Oct 29, 2026
- Latest report · revenue estimate
- $9.16B Oct 29, 2026
- Latest report · revenue vs estimate
- Above estimate Oct 29, 2026
- Latest report · EPS vs estimate
- Above estimate Oct 29, 2026
| Report date | Revenue · reported | Revenue · estimate | EPS · reported | EPS · estimate |
|---|---|---|---|---|
| Oct 29, 2026 | $9.40B | $9.16B | $4.5900 | $4.5200 |
| Jul 31, 2026 | $9.29B | $9.02B | $4.5000 | $4.4900 |
| May 1, 2026 | $8.78B | $8.60B | $4.3300 | $4.2700 |
| Feb 5, 2026 | $8.76B | $8.64B | $4.2000 | $4.1800 |
How to read these figures
Dates are when results were reported, not quarter ends. Amounts are in US dollars; EPS is per share. The source does not say whether EPS is basic, diluted or adjusted, so it can differ from the EPS in the income statement.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Sep 2025 | $8.62B | $1.93B | $4.09 (diluted) |
| Q4 FY2025 | $8.76B | $1.53B | $3.26 (diluted) |
| Q1 FY2026 | $8.78B | $1.86B | $3.98 (diluted) |
| Q2 FY2026 | $9.29B | $1.93B | $4.15 (diluted) |
What are the financial strengths and risks for Linde (LIN)?
Short answer
Cash and short-term investments were $0.00 at the Sep 30, 2026 balance-sheet date. This figure does not establish a cash runway.
Research dated 2026-09-12.
Operating cash flow has exceeded capital expenditure throughout the displayed quarterly series, leaving positive internally generated cash after project spending. Capital expenditure nevertheless consumes a substantial share of operating cash, and recent cash balances have fluctuated around a broadly stable range rather than compounding steadily.
Debt substantially exceeds cash and short-term investments, while liquidity ratios remain below parity. If margin pressure persists while project spending stays elevated, the cash retained after capital expenditure would narrow and the debt burden would become more consequential.
Data-derived red flags
- Inconsistent delivery — missed Wall Street EPS estimates in 0 of the last 4 reported quarters.
- Rich valuation — a P/E of 34.07 runs well above the Basic Materials sector’s ~19.90x, leaving little room for a miss.
What should you watch next at Linde (LIN)?
Short answer · as of
The next earnings report is expected on Feb 4, 2027.
Research dated 2026-09-12.
Watch for operating profit to recover alongside revenue and gross profit, which would support management’s description of the margin pressure as temporary. Continued sales growth without that recovery would indicate that volume or pricing strength is not reaching operating earnings.
The gap between operating cash flow and capital expenditure is the other practical checkpoint. Management is bringing investments into service while discussing backlog resilience and expects greater guidance clarity later, so backlog commentary, project commissioning and cash conversion should be read together at the scheduled earnings update.
What the records here don't tell us
- No forward revenue or earnings estimate is on file.
Checked against the records this page reads, on the dates shown above.
How does Linde compare with its peers?
Short answer
Linde's score ranks 3rd of 13 in the bounded comparison shown, against 12 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.
Research dated 2026-09-12.
Linde combines industrial-gas supply with the ability to design and construct the plants that make those gases. That engineering capability creates external project revenue and supports Linde’s own production network, while the geographic gas operations remain the much larger reporting base.
Its demand is also spread across healthcare, steel, electronics, aerospace, energy, food and beverage, chemicals, manufacturing and water treatment. This makes Linde’s revenue exposure broader than a business tied mainly to a narrow chemical product cycle, although capital intensity and industrial customer activity still shape cash generation.
| Company | Price | Market value | Score |
|---|---|---|---|
| $12.09 Nov 18, 2026 | $7.75B | 91 5-pillar Nov 18, 2026 | |
| $122.76 Nov 18, 2026 | $27.1B | 79 5-pillar Nov 18, 2026 | |
| Linde (LIN) — this page | $512.16 | $235B | 76 |
| $346.60 Nov 18, 2026 | $83.7B | 75 5-pillar Nov 18, 2026 | |
| $104.52 Nov 18, 2026 | $13.3B | 75 5-pillar Nov 18, 2026 | |
| $85.82 Nov 18, 2026 | $10.1B | 72 5-pillar Nov 18, 2026 | |
| $300.58 Nov 18, 2026 | $84.3B | 69 5-pillar Nov 18, 2026 | |
| $58.46 Nov 18, 2026 | $18.9B | 67 5-pillar Nov 18, 2026 | |
| $65.59 Nov 18, 2026 | $10.3B | 67 5-pillar Nov 18, 2026 | |
| $62.36 Nov 18, 2026 | $7.13B | 63 5-pillar Nov 18, 2026 | |
| $32.57 Nov 18, 2026 | $7.90B | 62 5-pillar Nov 18, 2026 | |
| $48.74 Nov 18, 2026 | $13.9B | 61 5-pillar Nov 18, 2026 | |
| $80.08 Nov 18, 2026 | $20.1B | 56 5-pillar Nov 18, 2026 |
Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.
The records behind this page
Analyst targets & estimates
What analysts have on file
- Price target, low to high
- $525.00 – $583.00
- Consensus target
- $558.00
- Median target
- $556.00
Consensus record · Captured .
Measured against a quoted price of $512.16 (as of Nov 18, 2026).
Insider activity
Form 4 records via FMP · Of the newest 100 records, those within the last 180 days, newest dated Nov 4, 2026
- Transactions
- 28
- Identified insiders
- 5
- Purchases
- 1
- Sales
- 5
- Other transactions
- 22
Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.
Who holds the shares?
Institutional ownership reported through 13F filings.
Tracked investors
Which of the 16 named investors we follow held LIN in their latest 13F filing, and what they did against the filing before it.
| Investor | Manager | 13F quarter | Portfolio weight | Value | Last quarter |
|---|---|---|---|---|---|
| Duquesne Family Office | Stanley Druckenmiller | Q3 2026 | 0% | $0 | Sold out (was $21.38M) |
How to read these figures
These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.
What has been published about Linde (LIN)?
What Investors Ask About Linde (LIN) — Basic Materials
Research dated 2026-09-12; the full attribution is under Sources. The last 2 questions are answered from this page's own dated data, not from the research.
What does Linde sell beyond oxygen and nitrogen?
Linde supplies process gases including hydrogen, helium, carbon dioxide, acetylene and specialty electronic gases. It also designs and constructs air-separation, hydrogen, natural-gas, olefin and synthesis-gas plants.
Why does Linde report Engineering apart from its regional operations?
Engineering captures process-plant design and construction for outside customers and Linde’s own gas facilities. The regional segments represent the much larger operating base spread across the Americas, Europe, the Middle East, Africa and Asia Pacific.
Are Linde’s latest margin headwinds already reversing?
The latest revenue, gross profit and net result improved, but operating profit declined. Management expects the headwinds to ease, while an operating-profit rebound would provide the financial confirmation.
Can Linde’s industrial-gas expansion be funded from operating cash flow?
Operating cash flow has remained above capital expenditure throughout the reported sequence, so current project spending has been internally covered at that level. The remaining spread matters because debt is far larger than cash and short-term investments.
What is the LIN stock price today?
The last price recorded for Linde plc (LIN), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
What is the LIN price target?
The analyst consensus price target for Linde plc (LIN), with its range and the date it was captured from FMP, is listed under Analyst targets & estimates on this page. Targets are analyst opinions and change often; they are not a Stock Expert AI forecast.
Research written by Codex (gpt-5.6-sol) on 2026-09-12. AI-authored analysis; source dates are listed under Sources. Reviewed by Sedat ANAK, Founder and Editor-in-Chief, on 2026-11-07.
Sources: the source register lists the 43 figures on this page — 1 from SEC filings and earnings calls, 35 from Financial Modeling Prep (FMP), 3 with no recorded source, 2 computed by us, formula shown in the register and 2 from Stock Expert AI's own score and rank. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.
Publication details and research sources
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com
Sources (as of 2026-09-12), by section of the research
ETFs that hold LIN
Funds in our ETF coverage that list LIN among the top 10 holdings on their fund page, largest weight first. Each weight is the fund's reported holding weight as of the date in its row.
